GenMark Diagnostics, Inc.·4

Aug 24, 6:11 PM ET

Mitchell Brian Andrew 4

4 · GenMark Diagnostics, Inc. · Filed Aug 24, 2020

Insider Transaction Report

Form 4
Period: 2020-08-20
Mitchell Brian Andrew
SVP, Operations
Transactions
  • Sale

    Common Stock

    2020-08-21$15.62/sh2,997$46,813176,198 total
  • Sale

    Common Stock

    2020-08-20$15.41/sh1,691$26,058179,195 total
Footnotes (3)
  • [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.
  • [F2]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 7/20/2020.
  • [F3]The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $15.44 to $15.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    wf-form4_159830704722915.xmlPrimary

    FORM 4